Stay informed with the latest updates for the inheritable blood disorders community.

Peer-Reviewed Journal Summaries
PT Study Focuses on Comprehensive Survey of Physical Activities Risks for 101 Activities
PT Study Focuses on Comprehensive Survey of Physical…
Medical
Providers: NHLBI Seeking Comment on Preliminary Hemophilia Inhibitors Measurement Protocols
Providers: NHLBI Seeking Comment on Preliminary Hemophilia…
Medical
ISTH Creates Bleeding Assessment Tool for Hemophilia Patients
ISTH Creates Bleeding Assessment Tool for Hemophilia Patients
Medical
Gene Therapy with Transplanted Cells Shows Promise in Hemophilia A Mice
Gene Therapy with Transplanted Cells Shows Promise in Hemophilia A Mice
Medical
Results of Bayer's PROTECT VIII Extension Study Announced
Results of Bayer's PROTECT VIII Extension Study Announced
Medical
Two New MASAC Documents Issued
Two New MASAC Documents Issued
Medical
Inhibitor Chapter Updated in Nurses’ Guide to Bleeding Disorders
Inhibitor Chapter Updated in Nurses’ Guide to Bleeding Disorders
Medical
Accredited Webinars on Management of Women with Bleeding Disorders Still Available
Accredited Webinars on Management of Women with Bleeding Disorders…
Medical
Hemlibra® Receives Expanded FDA Approval for Hemophilia A Patients Without Inhibitors
Hemlibra® Receives Expanded FDA Approval for Hemophilia A…
Medical
NHLBI Seeking Public Input to Drive FVIII Inhibitor Research
NHLBI Seeking Public Input to Drive FVIII Inhibitor Research
Medical
New Medscape Activity Makes the Case for Gene Therapy
New Medscape Activity Makes the Case for Gene Therapy
Medical
New Medscape Activity Features the Science Behind Gene Therapy
New Medscape Activity Features the Science Behind Gene Therapy
Medical
Shire Discontinuing Manufacture and Distribution of BEBULIN®
Shire Discontinuing Manufacture and Distribution of BEBULIN®
Medical
Inhibitor Webinar for Providers Available Now!
Inhibitor Webinar for Providers Available Now!
Peer-Reviewed Journal Summaries
Non-Attendance of Clinic Visits at Emory HTC the Focus of New Study
Non-Attendance of Clinic Visits at Emory HTC the Focus of New Study